Liver injury in COVID-19: clinical features and treatment management

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread to many countries around the world. In addition to lung disease, severe cases also displayed varying degrees of liver injury. This article will describe the latest developments regarding coronavirus and the pathogenesis of liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dongdong, Du, Qingru, Yan, Shengguang, Guo, Xu-Guang, He, Yehao, Zhu, Guodong, Zhao, Kewei, Ouyang, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188532/
https://www.ncbi.nlm.nih.gov/pubmed/34108015
http://dx.doi.org/10.1186/s12985-021-01593-1
_version_ 1783705348641652736
author Yu, Dongdong
Du, Qingru
Yan, Shengguang
Guo, Xu-Guang
He, Yehao
Zhu, Guodong
Zhao, Kewei
Ouyang, Shi
author_facet Yu, Dongdong
Du, Qingru
Yan, Shengguang
Guo, Xu-Guang
He, Yehao
Zhu, Guodong
Zhao, Kewei
Ouyang, Shi
author_sort Yu, Dongdong
collection PubMed
description Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread to many countries around the world. In addition to lung disease, severe cases also displayed varying degrees of liver injury. This article will describe the latest developments regarding coronavirus and the pathogenesis of liver injury, the prone population and clinical characteristics of these patients, as well as providing some suggestions for clinical treatment.
format Online
Article
Text
id pubmed-8188532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81885322021-06-09 Liver injury in COVID-19: clinical features and treatment management Yu, Dongdong Du, Qingru Yan, Shengguang Guo, Xu-Guang He, Yehao Zhu, Guodong Zhao, Kewei Ouyang, Shi Virol J Review Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread to many countries around the world. In addition to lung disease, severe cases also displayed varying degrees of liver injury. This article will describe the latest developments regarding coronavirus and the pathogenesis of liver injury, the prone population and clinical characteristics of these patients, as well as providing some suggestions for clinical treatment. BioMed Central 2021-06-09 /pmc/articles/PMC8188532/ /pubmed/34108015 http://dx.doi.org/10.1186/s12985-021-01593-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Yu, Dongdong
Du, Qingru
Yan, Shengguang
Guo, Xu-Guang
He, Yehao
Zhu, Guodong
Zhao, Kewei
Ouyang, Shi
Liver injury in COVID-19: clinical features and treatment management
title Liver injury in COVID-19: clinical features and treatment management
title_full Liver injury in COVID-19: clinical features and treatment management
title_fullStr Liver injury in COVID-19: clinical features and treatment management
title_full_unstemmed Liver injury in COVID-19: clinical features and treatment management
title_short Liver injury in COVID-19: clinical features and treatment management
title_sort liver injury in covid-19: clinical features and treatment management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188532/
https://www.ncbi.nlm.nih.gov/pubmed/34108015
http://dx.doi.org/10.1186/s12985-021-01593-1
work_keys_str_mv AT yudongdong liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT duqingru liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT yanshengguang liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT guoxuguang liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT heyehao liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT zhuguodong liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT zhaokewei liverinjuryincovid19clinicalfeaturesandtreatmentmanagement
AT ouyangshi liverinjuryincovid19clinicalfeaturesandtreatmentmanagement

Ejemplares similares